Research any topic before you write.
Find related topics. | Discover entities. | See connections. | Build a topical map.
Mefloquine, sold under the brand name Lariam among others, is a medication used to prevent or treat malaria. When used for prevention it is typically started before potential exposure and continued for several weeks after potential exposure. It can be used to treat mild or moderate malaria but is not recommended for severe malaria. It is taken by mouth.
The analysis highlights History, Culture, Applications and Research as prominent areas in the source structure around Mefloquine.
Source areas are shown by the number of related topics found in each part of the analysis. Use smaller areas too: they can reveal specialized angles and content gaps.
Smaller areas are not necessarily less important. They contain fewer connections in this analysis and can be useful for finding specialized angles or coverage gaps.
High-confidence facts extracted from structured source data. Use them as anchors for further research.
Browse the complete topic structure, not only the most central items. Less prominent entities and concepts can reveal missing angles, specialized context and useful research gaps. Each item opens a new analysis centered on that subject.
Deeper signals for content research, entity SEO and topical coverage. The plain-language headings explain what each technical view is useful for.
The extracted context around Mefloquine shows recurring relationship patterns in the source. For example, Mefloquine → Defense, FDA, Hoffman-LaRoche, II, III, Most, PPV, Public-Private Venture, Research, Smith Kline, US Department, Vietnam, Walter Reed Army Institute, WRAIR Another extracted example is Mefloquine → Afghanistan, Australian, Between, Canadian, December, German, Green Berets, In, UK, US Army. Use these groups to spot repeated connection types before inspecting the individual relationships.
Use these terms to understand the vocabulary surrounding the topic, not as a checklist for keyword stuffing.
effects drug malaria side use recommended used health liver include may hallucinations seizures pregnancy one resistance treatment psychiatric prevention lariam
TTTA extracted 132 structured relationships around Mefloquine. Examples in this analysis include Mefloquine → 3D model (JSmol) → Interactive image and Mefloquine → AHFS/Drugs.com → Monograph. The table shows each extracted connection, where it came from and its confidence.
| Subject | Predicate | Object | Confidence | Src |
|---|---|---|---|---|
| Mefloquine | 3D model (JSmol) | Interactive image | 1.00 | infobox |
| Mefloquine | AHFS/Drugs.com | Monograph | 1.00 | infobox |
| Mefloquine | ATC code | P01BC02 (WHO) | 1.00 | infobox |
| Mefloquine | CAS Number | 53230-10-7 Y | 1.00 | infobox |
| Mefloquine | ChEMBL | ChEMBL416956 N | 1.00 | infobox |
| Mefloquine | ChemSpider | 37171 Y | 1.00 | infobox |
| Mefloquine | Chirality | Racemic mixture | 1.00 | infobox |
| Mefloquine | CompTox Dashboard (EPA) | DTXSID50860636 | 1.00 | infobox |
| Mefloquine | Drug class | Antimalarial | 1.00 | infobox |
| Mefloquine | DrugBank | DB00358 Y | 1.00 | infobox |
| Mefloquine | Elimination half-life | 2 to 4 weeks | 1.00 | infobox |
| Mefloquine | Excretion | Primarily bile and feces; urine (9% as unchanged drug, 4% as primary metabolite) | 1.00 | infobox |
| Mefloquine | Formula | C17H16F6N2O | 1.00 | infobox |
| Mefloquine | KEGG | D04895 Y | 1.00 | infobox |
| Mefloquine | Legal status | AU: S4 (Prescription only) | 1.00 | infobox |
| Mefloquine | Legal status | CA: ℞-only | 1.00 | infobox |
| Mefloquine | Legal status | UK: POM (Prescription only) | 1.00 | infobox |
| Mefloquine | Legal status | US: ℞-only | 1.00 | infobox |
| Mefloquine | License data | US DailyMed: Mefloquine | 1.00 | infobox |
| Mefloquine | MedlinePlus | a603030 | 1.00 | infobox |
| Mefloquine | Metabolism | Extensive liver; main metabolite is inactive | 1.00 | infobox |
| Mefloquine | Molar mass | 378.318 g·mol−1 | 1.00 | infobox |
| Mefloquine | NIAID ChemDB | 005218 | 1.00 | infobox |
| Mefloquine | Other names | 2,8-Trifluoromethyl-β-hydroxy-α,N-tetramethylene-quinolinylethylamine | 1.00 | infobox |
| Mefloquine | Pregnancy category | AU: B3 | 1.00 | infobox |
| Mefloquine | PubChem CID | 40692 | 1.00 | infobox |
| Mefloquine | Routes of administration | Oral | 1.00 | infobox |
| Mefloquine | Trade names | Lariam, Mephaquin, Mefliam, others | 1.00 | infobox |
| Mefloquine | UNII | TML814419R | 1.00 | infobox |
| Mefloquine | is a | quinolinylethylamine | 0.90 | text |
The concept neighborhoods around Mefloquine bring nearby vocabulary together. In this analysis, examples include Use, Malaria and Effects. Use the clusters to find adjacent concepts and terminology that may deserve separate research.
For Mefloquine, one of the stronger structural bridges in this analysis connects Mefloquine with Overview. Bridges highlight paths between different parts of the map and can reveal research angles that are easy to miss in a flat list.
TTTA analyzes the structure around Mefloquine to surface related topics, entities, relationships, concept neighborhoods and bridge connections. Use the map to explore areas such as History, Culture, Applications & Research, including less central topics that may reveal useful research gaps. Automatically extracted connections are research leads rather than rewritten encyclopedia content.
Source: Wikipedia — Mefloquine · EN edition · Analysis: TopicsToTalkAbout